This bill enables pharmacists in New Jersey to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without an individual prescription, provided they complete a training program and obtain a standing order from the Commissioner of Health. Pharmacists are required to ensure that patients are HIV-negative, provide necessary counseling, and document the services in the patient's record. The bill also mandates that pharmacists notify the patient's primary care provider about the services rendered and offers civil liability protections for pharmacists acting in good faith. Additionally, it allows for a maximum supply of 90 days of PrEP without a prescription within a two-year period, after which a prescription is necessary for continued access.

Moreover, the legislation requires health insurance policies, including those for individual, group, and small employer plans, to cover PrEP and PEP without prior authorization or step therapy. However, if the FDA approves therapeutic equivalents, plans may impose such requirements on other formulations, as long as at least one version remains accessible without them. The bill ensures that reimbursements to pharmacists for these services are comparable to those for other non-physician practitioners and prohibits health insurance contracts from restricting pharmacists from dispensing these medications. Overall, the bill aims to improve access to HIV prevention and treatment services through pharmacists while maintaining established care standards.